Invention Grant
- Patent Title: Trispecific antagonists
-
Application No.: US16457343Application Date: 2019-06-28
-
Publication No.: US10647773B2Publication Date: 2020-05-12
- Inventor: Jackie Sheng , Bo Liu
- Applicant: GENSUN BIOPHARMA, INC.
- Applicant Address: US CA Newbury Park
- Assignee: GENSUN BIOPHARMA, INC.
- Current Assignee: GENSUN BIOPHARMA, INC.
- Current Assignee Address: US CA Newbury Park
- Agency: Morris, Manning & Martin, LLP
- Agent Michael X. Ye
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/28 ; A61P35/00 ; C07K16/22 ; C07K14/00 ; C07K14/71 ; C07K16/46 ; A61K39/00
Abstract:
Antitumor antagonists that bind specifically to immune checkpoint regulator and/or components of the angiogenesis pathways and/or components of the TGF pathway are disclosed. Also disclosed is a method of treating proliferative disorders with the antitumor antagonists.
Public/Granted literature
- US20200002439A1 TRISPECIFIC ANTAGONISTS Public/Granted day:2020-01-02
Information query
